<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
  • Menu
  • crown-logo-symbol-1-400x551

Find it Quickly

Get Started

Select the option that best describes what you are looking for

  • Services
  • Models
  • Scientific Information

Search Here For Services

Click Here to Start Over

Search Here For Models

Click Here to Start Over

Search Here For Scientific Information

Click Here to Start Over

In Vitro

Boost oncology drug discovery with XenoBase®, featuring the largest cell line selection and exclusive 3D organoid models. Benefit from OrganoidXplore™ and OmniScreen™ for rapid, in-depth analysis.

Learn More

In Vivo

Enhance drug development with our validated in vivo models, in vitro/ex vivo assays, and in silico modeling. Tailored solutions to optimize your candidates.

Learn More


Experience ISO-certified biobanking quality. Access top biospecimens from a global clinical network, annotated by experts for precise research.

Learn More

Biomarkers and Bioanalysis

Leverage our global labs and 150+ scientists for fast, tailored project execution. Benefit from our expertise, cutting-edge tech, and validated workflows for reliable data outcomes.

Learn More

Data Science and Bioinformatics

Harness your data and discover biomarkers with our top bioinformatics expertise. Maximize data value and gain critical insights to accelerate drug discovery and elevate projects.

Learn More


Accelerate innovative cancer treatments with our advanced models and precise drug screening for KRAS mutations, efficiently turning insights into clinical breakthroughs.

Learn More


Advance translational pharmacology with our diverse pre-clinical models, robust assays, and data science-driven biomarker analysis, multi-omics, and spatial biology.

Learn More

Drug Resistance

Our suite integrates preclinical solutions, bioanalytical read-outs, and multi-omics to uncover drug resistance markers and expedite discovery with our unique four-step strategy.

Learn More

Patient Tissue

Enhance treatments with our human tumor and mouse models, including xenografts and organoids, for accurate cancer biology representation.

Learn More


Apply the most appropriate in silico framework to your pharmacology data or historical datasets to elevate your study design and analysis, and to improve your chances of clinical success.

Learn More

Biomarker Analysis

Integrate advanced statistics into your drug development projects to gain significant biological insight into your therapeutic candidate, with our expert team of bioinformaticians.

Learn More


Accelerate your discoveries with our reliable CRISPR solutions. Our global CRISPR licenses cover an integrated drug discovery platform for in vitro and in vivo efficacy studies.

Learn More


Rely on our experienced genomics services to deliver high quality, interpretable results using highly sensitive PCR-based, real-time PCR, and NGS technologies and advanced data analytics.

Learn More

In Vitro High Content Imaging

Gain more insights into tumor growth and disease progression by leveraging our 2D and 3D fluorescence optical imaging.

Learn More

Mass Spectrometry-based Proteomics

Next-generation ion mobility mass spectrometry (MS)-based proteomics services available globally to help meet your study needs.

Learn More

Ex Vivo Patient Tissue

Gain better insight into the phenotypic response of your therapeutic candidate in organoids and ex vivo patient tissue.

Learn More

Spatial Multi-Omics Analysis

Certified CRO services with NanoString GeoMx Digital Spatial Profiling.

Learn More

Biomarker Discovery

De-risk your drug development with early identification of candidate biomarkers and utilize our biomarker discovery services to optimize clinical trial design.

Learn More

DMPK Services

Rapidly evaluate your molecule’s pharmaceutical and safety properties with our in vivo drug metabolism and pharmacokinetic (DMPK) services to select the most robust drug formulations.

Learn More

Efficacy Testing

Explore how the novel HuGEMM™ and HuCELL™ platforms can assess the efficacy of your molecule and accelerate your immuno-oncology drug discovery programs.

Learn More

Laboratory Services

Employ cutting-edge multi-omics methods to obtain accurate and comprehensive data for optimal data-based decisions.

Learn More

Pharmacology & Bioanalytical Services

Leverage our suite of structural biology services including, recombinant protein expression and protein crystallography, and target validation services including RNAi.

Learn More


Find the most appropriate screen to accelerate your drug development: discover in vivo screens with MuScreen™ and in vitro cell line screening with OmniScreen™.

Learn More


Carry out safety pharmacology studies as standalone assessments or embedded within our overall toxicological profiling to assess cardiovascular, metabolic and renal/urinary systems.

Learn More

Our Company

Global CRO in California, USA offering preclinical and translational oncology platforms with high-quality in vivo, in vitro, and ex vivo models.

Learn More

Our Purpose

Learn more about the impact we make through our scientific talent, high-quality standards, and innovation.

Learn More

Our Responsibility

We build a sustainable future by supporting employee growth, fostering leadership, and exceeding customer needs. Our values focus on innovation, social responsibility, and community well-being.

Learn More

Meet Our Leadership Team

We build a sustainable future by fostering leadership, employee growth, and exceeding customer needs with innovation and social responsibility.

Learn More

Scientific Advisory Board

Our Scientific Advisory Board of experts shapes our strategy and ensures top scientific standards in research and development.

Learn More

News & Events

Stay updated with Crown Bioscience's latest news, achievements, and announcements. Check our schedule for upcoming events and plan your visit.

Learn More

Career Opportunities

Join us for a fast-paced career addressing life science needs with innovative technologies. Thrive in a respectful, growth-focused environment.

Learn More

Scientific Publications

Access our latest scientific research and peer-reviewed articles. Discover cutting-edge findings and insights driving innovation and excellence in bioscience.

Learn More


Discover valuable insights and curated materials to support your R&D efforts. Explore the latest trends, innovations, and expertly curated content in bioscience.

Learn More


Explore our blogs for the latest insights, research breakthroughs, and industry trends. Stay educated with expert perspectives and in-depth articles driving innovation in bioscience.

Learn More

  • Platforms
  • Target Solutions
  • Technologies
  • Service Types

Humanized Mouse Clinical Trials for Immunotherapy Development

Recent posts have covered the different types of mouse clinical trial (MCT) and which is most suited to any given drug development program. These posts all consider immunodeficient mice, and the progression of oncology agents such as targeted drugs or chemotherapy. However, MCT can also be used to progress immunotherapies, but require the use of humanized mice.

For researchers interested in running MCT with humanized mice, the current industry gold standard are humanized mice from The Jackson Laboratory. It should be noted that, in addition to the massive amount of work around development and ongoing characterization, there are limitations to these types of mouse models.

There is donor variability and that is something that needs to be considered when using humanized mice - that you are not going to get the same donor every time.

How Do You Choose Models and Design an Mouse Clinical Trial using Humanized Mice?

Within a patient-derived xenograft (PDX) collection where you have already identified your lead indication, PDX models can be screened for your specific checkpoint target expression (e.g. PD-1) and all appropriate models can be selected and recruited to a mouse clinical trial.

This is performed in a similar way to choosing models for a standard study, e.g. through a database of characterization data, TMAs etc.

1+1 Mouse Clinical Trials are Useful for Immuno-Oncology Studies

A common MCT design is 1+1, which has already been discussed in our previous posts: one animal for vehicle and one animal for your agent of interest.

Due to the variation between donors, when conducting humanized MCTs, it is best to have multiple PDX models in addition to multiple stem cell donors, in other words utilizing a checkerboard design. Endpoints for studies such as these would include:

  • tumor growth inhibition
  • tumor infiltrating lymphocyte assessment by flow cytometry
  • as well as histology.

Use Checkerboard Design Studies to Overcome Variability in Response

To help you visualize what a checkerboard designed study looks like your different PDX models would be positioned across (x-axis), with different donors shown down the side (y-axis).

Anti-PD-1 response across a HSC donor population in SCLC PDX models.

When utilizing this type of study design it becomes apparent that not a single model or donor will have a response across the board. So not a single model responds to all donors, nor a single donor responds with all PDX models. The only way to overcome this limitation is by doing these kind of checkerboard studies.

Risk of Redundant Data May Increase n Number

With these types of humanized models, you will always see dropouts and lose some animals, meaning some data may not be generated. Running a 1+1 study means there is always a risk – if you lose the vehicle or a treatment group that data set becomes redundant. However, you can always increase the n numbers per group to compensate for this effect.

Humanized MCTs are Useful for Advanced Drug Candidates

These types of checkerboard study designs are very useful to interrogate PDX models, especially when looking to investigate combination therapies as well as patient diversity. PDX models in addition to immuno-oncology models are now helping to answer the many questions being raised with the evolution of immunotherapeutics.

The humanized system (using reconstitution of the human system in mice) is something that is still in development and proving to be very relevant in providing positive results that can be correlated to the clinic.

Keeping in mind that the humanized mouse system is more for advanced assets, selecting these models should be done with careful consideration relative to the stage of your agent.

Further Reading

Related Posts